627 related articles for article (PubMed ID: 21963677)
1. Immune responses to influenza virus infection.
Kreijtz JH; Fouchier RA; Rimmelzwaan GF
Virus Res; 2011 Dec; 162(1-2):19-30. PubMed ID: 21963677
[TBL] [Abstract][Full Text] [Related]
2. Novel vaccines against influenza viruses.
Kang SM; Song JM; Compans RW
Virus Res; 2011 Dec; 162(1-2):31-8. PubMed ID: 21968298
[TBL] [Abstract][Full Text] [Related]
3. Virus-specific T cells as correlate of (cross-)protective immunity against influenza.
Altenburg AF; Rimmelzwaan GF; de Vries RD
Vaccine; 2015 Jan; 33(4):500-6. PubMed ID: 25498210
[TBL] [Abstract][Full Text] [Related]
4. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
5. Universal influenza vaccines, science fiction or soon reality?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
[TBL] [Abstract][Full Text] [Related]
6. Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines.
Hillaire ML; Osterhaus AD; Rimmelzwaan GF
J Biomed Biotechnol; 2011; 2011():939860. PubMed ID: 22007149
[TBL] [Abstract][Full Text] [Related]
7. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
Front Immunol; 2019; 10():756. PubMed ID: 31105689
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
9. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
10. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
11. Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus.
Zhang Y; Xu C; Zhang H; Liu GD; Xue C; Cao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31052339
[TBL] [Abstract][Full Text] [Related]
12. Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.
Laidlaw BJ; Decman V; Ali MA; Abt MC; Wolf AI; Monticelli LA; Mozdzanowska K; Angelosanto JM; Artis D; Erikson J; Wherry EJ
PLoS Pathog; 2013 Mar; 9(3):e1003207. PubMed ID: 23516357
[TBL] [Abstract][Full Text] [Related]
13. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
[TBL] [Abstract][Full Text] [Related]
14. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
[TBL] [Abstract][Full Text] [Related]
15. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
16. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
18. Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection.
de Vries RD; Nieuwkoop NJ; Pronk M; de Bruin E; Leroux-Roels G; Huijskens EGW; van Binnendijk RS; Krammer F; Koopmans MPG; Rimmelzwaan GF
Vaccine; 2017 Jan; 35(2):238-247. PubMed ID: 27914742
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity.
Belshe RB; Coelingh K; Ambrose CS; Woo JC; Wu X
Vaccine; 2010 Feb; 28(9):2149-56. PubMed ID: 20003926
[TBL] [Abstract][Full Text] [Related]
20. Influenza vaccines: 'tailor-made' or 'one fits all'.
Saletti G; Gerlach T; Rimmelzwaan GF
Curr Opin Immunol; 2018 Aug; 53():102-110. PubMed ID: 29734023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]